Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: A case series

Head and Neck

Volumn 27, Issue 9, 2005, Pages 748-756

  Sturgis, Erich M ^a   Moore, Brian A ^a   Glisson, Bonnie S ^a   Kies, Merrill S ^a   Shin, Dong M ^b   Byers, Robert M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Head and neck cancer; Neoadjuvant induction chemotherapy; Oral cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; IFOSFAMIDE; PACLITAXEL; TAXANE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; ALOPECIA; ANOREXIA; ARTHRALGIA; CANCER CENTER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIZZINESS; DRUG RESPONSE; FATIGUE; FEMALE; FOLLOW UP; GLOSSECTOMY; HEADACHE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; NECK DISSECTION; NEUTROPENIA; NUTRITIONAL STATUS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RASH; REVIEW; SQUAMOUS CELL CARCINOMA; TASTE DISORDER; TINNITUS; TONGUE CARCINOMA; VOMITING;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; GLOSSECTOMY; HUMANS; MALE; NECK DISSECTION; NEOADJUVANT THERAPY; PACLITAXEL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TONGUE NEOPLASMS;

EID: 24644463185     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20240     Document Type: Review

References (19)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
3. Shemen LJ, Klotz J, Schottenfeld D, Strong EW. Increase of tongue cancer in young men. JAMA 1984;252:1857.
4. Depue RH. Rising mortality from cancer of the tongue in young white males. N Engl J Med 1986;315:647.
5. Schantz SP, Byers RM, Goepfert H. Tobacco and cancer of the tongue in young adults. JAMA 1988;259:1943-1944.
6. Myers JN, Elkins T, Roberts D, Byers RM. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000;122:44-51.
7. Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA 2000;283:2975-2978.
8. Licitra L, Grandi C, Guzzo M, et al. Primary chemotherapy in respectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 2003;21:327-333.
9. Pugliano FA, Picorillo JF, Zequeira MR, Fredrickson JM, Perez CA, Simpson JR. Clinical-severity staging system for oral cavity cancer: five-year survival rates. Otolaryngol Head Neck Surg 1999;120:38-45.
10. Basu S, Khanra M, Dash B, Majumdar J, Biswas J, Chaudhuri P. The role of neoadjuvant and adjuvant chemotherapy regimens consisting of different combinations of drugs in the treatment of advanced oral cancer. Med Oncol 1999;16:199-203.
11. Poulsen M, Aldren C, Tripcony L, Quenten W. Is surgery necessary in classification III and stage IV cancer of the head and neck that responds to induction chemotherapy? Arch Otolaryngol Head Neck Surg 1996;122:467-471.
12. Lore JM, Diaz-Ordaz E, Spaulding M, et al. Improved survival with preoperative chemotherapy followed by resection uncompromised by tumor response for advanced squamous cell carcinoma of the head and neck. Am J Surg 1995;170:506-511.
13. Okura M, Hiranuma T, Adachi T, et al. Induction chemotherapy is associated with an increase in the incidence of locoregional recurrence in patients with carcinoma of the oral cavity, results from a single institution. Cancer 1998;82:804-815.
14. Shin DM. Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Semin Oncol 2000;27 (suppl 1):36-40.
15. Shin DM, Glisson BS, Khuri FR, et al. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol 1998;16:1325-1330.
16. Schantz SP, Hsu TC, Ainslie N, Moser RP. Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosome damage. JAMA 1989;262;3313-3315.
17. Regezi JA, Dekker NP, McMillan A, et al. p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients <35 versus >75 years. Oral Oncol 1999;35:379-383.
18. Lingen MW, Chang KW, McMurray SJ, et al. Over expression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck 2000;22:328-335.
19. Darton SJ, Archer VR, Stocken DD, et al. Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival. J Clin Oncol 2003;21:4009-4015.